Olopatadine HCL 0.1% Ophthalmic Solution
Posted Date:
Sep 24, 2026
Feb 15, 2028
Awarded Date:
Feb 15, 2023
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D222R0117 | Olopatadine HCL 0.1% Ophthalmic Solution | |
| Synopsis | ||
|
Olopatadine HCL 0.1% Ophthalmic Solution .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D222R0117 | Olopatadine HCL 0.1% Ophthalmic Solution | |
| Synopsis | ||
|
Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D222R0117 | 65--Pharm Manuf/Distr Div - FSA | |
| Synopsis | ||
|
65--Pharm Manuf/Distr Div - FSA .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D222R0117 | Olopatadine HCL 0.1% Ophthalmic Solution | |
| Synopsis | ||
|
Olopatadine HCL 0.1% Ophthalmic Solution .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D222R0117 | Olopatadine HCL 0.1% Ophthalmic Solution | |
| Synopsis | ||
|
Olopatadine HCL 0.1% Ophthalmic Solution .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
